Benoit Grellier
Overview
Explore the profile of Benoit Grellier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ricordel M, Foloppe J, Antoine D, Findeli A, Kempf J, Cordier P, et al.
Cancers (Basel)
. 2018 Jul;
10(7).
PMID: 29996551
Oncolytic virus (OV) therapy has emerged as a promising approach for cancer treatment with the potential to be less toxic and more efficient than classic cancer therapies. Various types of...
2.
Tosch C, Bastien B, Barraud L, Grellier B, Nourtier V, Gantzer M, et al.
J Immunother Cancer
. 2017 Sep;
5(1):70.
PMID: 28923084
Background: Advanced non-small cell lung cancer patients receiving TG4010, a therapeutic viral vaccine encoding human Mucin 1 and interleukin-2 in addition to standard chemotherapy, displayed longer overall survival in comparison...
3.
Grellier B, Le Pogam F, Vitorino M, Starck J, Geist M, Duong V, et al.
MAbs
. 2014 Feb;
6(2):533-46.
PMID: 24492308
The humanized monoclonal antibody H27K15 specifically targets human CD115, a type III tyrosine kinase receptor involved in multiple cancers and inflammatory diseases. Binding of H27K15 to hCD115 expressing cells inhibits...
4.
Haegel H, Thioudellet C, Hallet R, Geist M, Menguy T, Le Pogam F, et al.
MAbs
. 2013 Aug;
5(5):736-47.
PMID: 23924795
Cancer progression has been associated with the presence of tumor-associated M2-macrophages (M2-TAMs) able to inhibit anti-tumor immune responses. It is also often associated with metastasis-induced bone destruction mediated by osteoclasts....